| 04/30/2026 6:15 AM | OptimizeRx (1448431) Filer | Form DEF 14A | |
| 04/30/2026 6:16 AM | OptimizeRx (1448431) Filer | Form ARS | |
| 04/22/2026 9:57 AM | OptimizeRx (1448431) Issuer Presti Mariyamma Varghese (2131226) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/05/2026 3:09 PM | OptimizeRx (1448431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/13/2026 10:49 AM | Odence-Ford Marion (1845002) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 4:43 PM | OptimizeRx (1448431) Issuer Silvestro Stephen L (1773461) Reporting | Form 4/A | |
| 12/23/2025 3:52 PM | OptimizeRx (1448431) Issuer Stelmakh Edward (1887046) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 3:53 PM | Besch Doug (1947731) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 3:53 PM | Odence-Ford Marion (1845002) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 3:54 PM | OptimizeRx (1448431) Issuer Silvestro Stephen L (1773461) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/23/2025 3:55 PM | Greco Theresa (1998771) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for OPRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for OptimizeRx and its competitors with MarketBeat's FREE daily newsletter.
|
| 12/23/2025 1:23 PM | OptimizeRx (1448431) Issuer Stelmakh Edward (1887046) Reporting | Form 4/A | |
| 12/22/2025 9:07 AM | Besch Doug (1947731) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 9:07 AM | D'Silva Andrew J. (2083717) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 9:08 AM | Merrell Brendan W. (2090383) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 9:09 AM | Odence-Ford Marion (1845002) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 9:10 AM | OptimizeRx (1448431) Issuer Silvestro Stephen L (1773461) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 9:10 AM | OptimizeRx (1448431) Issuer Stelmakh Edward (1887046) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 6:46 PM | Merrell Brendan W. (2090383) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 6:43 PM | D'Silva Andrew J. (2083717) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2025 8:55 AM | Merrell Brendan W. (2090383) Reporting OptimizeRx (1448431) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 11/10/2025 8:55 AM | Merrell Brendan W. (2090383) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/07/2025 4:51 PM | D'Silva Andrew J. (2083717) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/06/2025 3:13 PM | OptimizeRx (1448431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/03/2025 7:12 PM | Greco Theresa (1998771) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/31/2025 10:03 AM | OptimizeRx (1448431) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G | |
| 10/07/2025 5:46 PM | Odence-Ford Marion (1845002) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2025 4:52 PM | Besch Doug (1947731) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2025 5:25 PM | OptimizeRx (1448431) Issuer Stelmakh Edward (1887046) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2025 5:26 PM | OptimizeRx (1448431) Issuer Silvestro Stephen L (1773461) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2025 10:25 AM | D'Silva Andrew J. (2083717) Reporting OptimizeRx (1448431) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 10/07/2025 10:26 AM | D'Silva Andrew J. (2083717) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2025 12:55 PM | OptimizeRx (1448431) Issuer Spangler Patrick D (1296525) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/29/2025 1:31 PM | OptimizeRx (1448431) Subject Spangler Patrick D (1296525) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/25/2025 3:29 PM | Odence-Ford Marion (1845002) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 3:32 PM | OptimizeRx (1448431) Issuer Silvestro Stephen L (1773461) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 2:16 PM | Besch Doug (1947731) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 2:17 PM | Greco Theresa (1998771) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 2:21 PM | OptimizeRx (1448431) Issuer Stelmakh Edward (1887046) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/19/2025 6:44 AM | OptimizeRx (1448431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/08/2025 3:02 PM | OptimizeRx (1448431) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
|
| 07/16/2025 10:35 AM | OptimizeRx (1448431) Subject ROYCE & ASSOCIATES LP (906304) Filed by | Form SCHEDULE 13G/A | |
| 06/24/2025 6:45 AM | OptimizeRx (1448431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/12/2025 3:31 PM | OptimizeRx (1448431) Issuer WASSON GREGORY D (1188827) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 3:33 PM | OptimizeRx (1448431) Issuer Vos Ellen O'Connor (1534357) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 3:34 PM | OptimizeRx (1448431) Issuer Spangler Patrick D (1296525) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 3:35 PM | Lang James Paul (1703090) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 3:36 PM | KLEMA CATHY (1181157) Reporting OptimizeRx (1448431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |